Midatech Pharma PLC-ADR (NASDAQ:MTP)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $0.71, but opened at $0.67. Midatech Pharma shares last traded at $0.64, with a volume of 2,497,657 shares trading hands.

The firm’s fifty day moving average price is $0.94 and its 200 day moving average price is $1.28. The stock has a market capitalization of $2.06 million, a price-to-earnings ratio of -1.39 and a beta of 2.61.

A hedge fund recently bought a new stake in Midatech Pharma stock. Morgan Stanley bought a new stake in Midatech Pharma PLC-ADR (NASDAQ:MTP) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 50,000 shares of the company’s stock, valued at approximately $72,000. Morgan Stanley owned 1.63% of Midatech Pharma as of its most recent SEC filing. 2.15% of the stock is owned by institutional investors.

Midatech Pharma Company Profile (NASDAQ:MTP)

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer.

See Also: What is the S&P/ASX 200 Index?

Receive News & Ratings for Midatech Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midatech Pharma and related companies with MarketBeat.com's FREE daily email newsletter.